TORONTO, ONTARIO, August 9, 2022 – NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced it has entered into a consulting agreement with one of the Company’s directors; Grishanth Ram.
To support the recently announced accelerated growth strategy and executive changes, NeuPath has entered into a consulting agreement with Grishanth Ram in an advisory capacity to support the Executive Chair in the transition to her new role. The term of the consulting agreement is for two months ending September 21, 2022.
Mr. Ram has been a member of the NeuPath board of directors since June 25, 2020. Prior to joining the board of directors, Mr. Ram served as the Chief Executive Officer of NeuPath from March 2018 to February 2019, and was NeuPath’s Executive Director from February 2019 to December 2019. Mr. Ram will continue to serve on NeuPath’s board of directors throughout the term of his consulting agreement.
Please click here to see the full PDF Press Release.